Sign In
Buy DHR
$178.08
+1.97 (+1.12%)
At Close: Jun 03, 2026
The 3 Most Undervalued Healthcare Stocks to Buy in September 2023
11:04am, Wednesday, 13'th Sep 2023
Healthcare is a sector that has underperformed the broader stock market this year. The S&P 500 Health Care Sector Index is down over 2.50% year-to-date versus a 17% gain in the benchmark S&P 500 index
The 3 Best Pharma Stocks to Buy Now: September 2023
09:14am, Friday, 08'th Sep 2023
The pharmaceutical sector will always be a sector in constant evolution and growth. As technology advances, the companies that make life in this sector will always be applying it, as well as implement
Here's Why You Should Steer Clear of Danaher (DHR) Stock Now
02:17pm, Tuesday, 05'th Sep 2023
Lower demand for COVID-related products, raw material cost inflation and foreign currency headwinds weigh on Danaher's (DHR) operations.
Danaher and Veralto to Webcast Investor and Analyst Meeting
06:00pm, Thursday, 31'st Aug 2023
WASHINGTON , Aug. 31, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) will host a live video webcast of Veralto's Investor and Analyst Meeting on September 6, 2023 beginning at approximately 12:0
Gurus' Top Stock Picks for the 2nd Quarter
03:45pm, Thursday, 31'st Aug 2023
The second quarter of 2023 was characterized by moderating inflation and signs the economy remains resilient despite interest rates rising. As such, the S&P 500 gained 7.90% during the three months en
When ChatGPT Misses the Mark: 3 Stocks It Got Very Wrong
07:00am, Thursday, 31'st Aug 2023
Artificial Intelligence ( AI ) has received incredible attention this year due to the public release of OpenAI's ChatGPT. Its profound capabilities have successfully captured the imaginations of a s
Danaher: A Lost Year
06:37pm, Wednesday, 30'th Aug 2023
Danaher Corporation benefited from the Covid-19 period and saw strong growth, aided by bolt-on deals and reasonable leverage. The company acquired the biopharma business from General Electric in a $21
Danaher (DHR) to Acquire Abcam, Boost Life Sciences Unit
03:02pm, Tuesday, 29'th Aug 2023
Danaher (DHR) is set to acquire Abcam in a $5.7 billion deal, boosting its Life Sciences portfolio while solving some of the world's greatest healthcare challenges.
Danaher Buys Abcam for $5.7 Billion to Expand Its Product Offerings
04:55pm, Monday, 28'th Aug 2023
Medical tool supplier Danaher (DHR) is expanding its product offerings by purchasing British biotech firm Abcam Plc (ABCM) for $5.7 billion, including debt.
Danaher acquires biotech supplier Abcam for $5.7B
09:32am, Monday, 28'th Aug 2023
Danaher (NYSE:DHR) said it will be acquiring UK-based biotechnology supplier Abcam (AIM:ABC) for $24 per share or a total enterprise value of about $5.7 billion. Danaher (NYSE:DHR) beat out rivals who
Medical tech firm Danaher to buy Abcam in deal valued at $5.7 bln
08:33am, Monday, 28'th Aug 2023
Danaher Corp said on Monday it would buy smaller rival Abcam Plc in a deal valued at $5.7 billion including debt, as the medical tools supplier eyes bigger contracts by expanding its services.
Danaher to Buy Abcam in $5.7 Billion Deal. Investors Don't Like the Premium.
08:32am, Monday, 28'th Aug 2023
The industrial scientific-supplies company agrees to acquire all shares outstanding for $24.00 each.
Abcam agrees to be acquired by Danaher in $5.7B deal
07:54am, Monday, 28'th Aug 2023
Abcam Plc stock ABCM, +3.87% was up 0.4% in premarket trades Monday after it said it agreed to be acquired by Danaher Corp. DHR, +0.78% for $24 a share in cash in a deal that values the maker of antib
Exclusive: Danaher in the lead to acquire biomedical equipment vendor Abcam-sources
02:04pm, Friday, 25'th Aug 2023
Danaher Corp is in the lead to acquire Abcam Plc , a provider of supplies to life science researchers with a market value of $5.1 billion, as it expands its biomedical offerings, people familiar with
4 moments from Jim Cramer's August Monthly Meeting of the CNBC Investing Club
03:28pm, Thursday, 17'th Aug 2023
Here's a sneak peek.
